Hainan Haiyao Stock Hits Day Low of CNY 5.91 Amid Price Pressure

Hainan Haiyao Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of CNY 5.91. The company’s stock has declined by 7.13% on February 26, 2026, contrasting sharply with the China Shanghai Composite, which fell by only 1.26% during the same period. Over the past week, Hainan Haiyao has seen a decrease of 3.54%, and its performance over the last month has been even more pronounced, with a drop of 15.75%. Year-to-date, the stock has underperformed significantly, showing a decline of 16.22%, while the broader market has gained 2.85%. Financial metrics indicate ongoing challenges for Hainan Haiyao, with net sales falling by 16.79% in the latest quarter and a staggering net profit loss of CNY 825.49 million. The company has reported negative results for seven consecutive quarters, raising concerns about its long-term viability. With a high debt-to-equity ratio of 8.89 and a return on equity of -384.85%, the company is navigating a difficult financial landscape.